Effect of hypocholesterolemic agents on central nervous system cholesterol biosynthesis. II. AY-9944 and AY-9944 plus zuclomiphene.
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002474:Cell-Free System; D002784:Cholesterol / Q000096:biosynthesis*; D002996:Clomiphene / Q000031:analogs & derivatives* / Q000494:pharmacology; D003510:Cyclohexanes / Q000494:pharmacology*; D004347:Drug Interactions; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008798:Mevalonic Acid / Q000378:metabolism; D051381:Rats; D013261:Sterols / Q000096:biosynthesis; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride / Q000494:pharmacology*
D000924:Anticholesteremic Agents; D003510:Cyclohexanes; D013261:Sterols; D002996:Clomiphene; D001371:trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; D002784:Cholesterol; D008798:Mevalonic Acid